NR4A3
(Nuclear Receptor Subfamily 4, Group A, Member 3 (NR4A3))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-NR4A3 antibody (Catalog #: ARP45646_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
NR4A3
Reaktivität: Human, Affe, Schwein, Ratte
Wirt: Synthetic
BP
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
NR4A3
(Nuclear Receptor Subfamily 4, Group A, Member 3 (NR4A3))
Synonyme
CHN Peptide, CSMF Peptide, MINOR Peptide, NOR1 Peptide, TEC Peptide, AI573420 Peptide, NOR-1 Peptide, Nor1 Peptide, NOR-2 Peptide, NR4A3 Peptide, Nr4a3 Peptide, nuclear receptor subfamily 4 group A member 3 Peptide, nuclear receptor subfamily 4, group A, member 3 Peptide, NR4A3 Peptide, Nr4a3 Peptide, nr4a3 Peptide
Hintergrund
NR4A3 is a member of the steroid-thyroid hormone-retinoid receptor superfamily. NR4A3 may act as a transcriptional activator. The protein can efficiently bind the NGFI-B Response Element (NBRE). Three different versions of extraskeletal myxoid chondrosarcomas (EMCs) are the result of reciprocal translocations between NR4A3 gene and other genes.
Alias Symbols: CHN, CSMF, MINOR, NOR1, TEC
Protein Interaction Partner: COPS5,RPS6KA1,SIX3,SIX3